OTC Markets OTCPK - Delayed Quote USD

Ayala Pharmaceuticals, Inc. (ADXS)

0.1203
+0.0888
+(281.30%)
At close: June 12 at 8:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13
13
692
3,506
3,708
Cost of Revenue
13
13
602
3,506
3,708
Gross Profit
0
0
90
0
0
Operating Expense
36,266
36,266
37,593
39,218
29,777
Operating Income
-36,266
-36,266
-37,503
-39,218
-29,777
Net Non Operating Interest Income Expense
-15,718
-15,718
74
-260
56
Pretax Income
-51,984
-51,984
-37,429
-39,478
-29,721
Tax Provision
-3,912
-3,912
584
776
425
Net Income Common Stockholders
-48,072
-48,072
-38,013
-40,254
-30,146
Diluted NI Available to Com Stockholders
-48,072
-48,072
-38,013
-40,254
-30,146
Basic EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Diluted EPS
-7.99
-7.99
-13.13
-2.80
-3.06
Basic Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Diluted Average Shares
6,019.0630
6,019.0630
2,895.1300
14,398.9050
9,860.6100
Total Operating Income as Reported
-36,266
-36,266
-37,503
-39,218
-29,777
Total Expenses
36,279
36,279
38,195
42,724
33,485
Net Income from Continuing & Discontinued Operation
-48,072
-48,072
-38,013
-40,254
-30,146
Normalized Income
-48,072
-48,072
-38,013
-40,254
-30,146
Interest Income
28
28
74
--
56
Interest Expense
15,746
15,746
0
260
--
Net Interest Income
-15,718
-15,718
74
-260
56
EBIT
-36,238
-36,238
-37,429
-39,218
-29,777
EBITDA
-35,869
-35,869
-37,267
-39,050
-29,595
Reconciled Cost of Revenue
13
13
602
3,506
3,708
Reconciled Depreciation
369
369
162
168
182
Net Income from Continuing Operation Net Minority Interest
-48,072
-48,072
-38,013
-40,254
-30,146
Normalized EBITDA
-35,869
-35,869
-37,267
-39,050
-29,595
Tax Rate for Calcs
0.0001
0.0001
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 5/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FLUI.ST Fluicell AB (publ)
11.10
-5.13%
 
RLFTF Relief Therapeutics Holding SA
2.8100
+1.26%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
NRXPW NRx Pharmaceuticals, Inc.
0.0890
-14.42%
 
XTLB XTL Biopharmaceuticals Ltd.
1.1200
-6.67%
 
VAXX Vaxxinity, Inc.
0.0001
0.00%
 
ATXI Avenue Therapeutics, Inc.
0.2082
-26.59%
 
VCNX Vaccinex, Inc.
0.8200
+2.50%
 
ATHA Athira Pharma, Inc.
0.3040
-1.78%
 
GXE.F Galapagos NV
24.76
+0.08%